|
US4863896A
(en)
*
|
1984-05-03 |
1989-09-05 |
Technology Unlimited, Inc. |
Diabetic control by combined insulin forms
|
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
US5582837A
(en)
|
1992-03-25 |
1996-12-10 |
Depomed, Inc. |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
|
|
ATE173159T1
(de)
|
1992-03-25 |
1998-11-15 |
Depomed Systems Inc |
Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
|
|
WO1997047285A1
(en)
|
1996-06-10 |
1997-12-18 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
CA2290624C
(en)
|
1997-06-06 |
2006-12-05 |
John W. Shell |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
AU3999699A
(en)
*
|
1998-05-19 |
1999-12-06 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
|
CA2389236A1
(en)
|
1999-11-02 |
2001-05-10 |
Depomed, Inc. |
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
|
|
ES2270982T3
(es)
|
2000-02-04 |
2007-04-16 |
Depomed, Inc. |
Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero.
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
US6451808B1
(en)
|
2000-10-17 |
2002-09-17 |
Depomed, Inc. |
Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
|
|
JP2004532259A
(ja)
|
2001-05-29 |
2004-10-21 |
デポメッド ディベロップメント リミティド |
胃食道逆流症及び夜間に胃酸分泌が回復する現象の治療方法
|
|
JP2005508358A
(ja)
|
2001-10-25 |
2005-03-31 |
デポメド・インコーポレイテッド |
胃滞留型ロサルタン投与量を用いる治療方法
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
EP1448252B1
(de)
*
|
2001-11-16 |
2007-04-18 |
Medinnovation AG |
Medizinische pumpvorrichtung
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
US8211430B2
(en)
*
|
2005-03-04 |
2012-07-03 |
Curedm Group Holdings, Llc |
Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
|
|
CN101237854B
(zh)
*
|
2005-05-23 |
2013-03-27 |
Sdg公司 |
将胰岛素输送到哺乳动物的脂构建体
|
|
US20110135725A1
(en)
|
2005-05-23 |
2011-06-09 |
Sdg, Inc. |
Lipid Construct for Delivery of Insulin to a Mammal
|
|
US8962015B2
(en)
|
2007-09-28 |
2015-02-24 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
WO2010080976A1
(en)
*
|
2009-01-09 |
2010-07-15 |
Sdg, Inc. (An Ohio Corporation) |
Insulin therapies for the treatment of diabetes, diabetes related ailments, and/or diseases or conditions other than diabetes or diabetes related ailments
|
|
EP2727587A1
(en)
*
|
2012-10-30 |
2014-05-07 |
Pharnext |
Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
|
|
WO2018169954A1
(en)
|
2017-03-13 |
2018-09-20 |
Sdg, Inc. |
Lipid-based nanoparticles with enhanced stability
|
|
EP3483629B1
(en)
*
|
2017-11-09 |
2021-12-29 |
Veoneer Sweden AB |
Detecting a parking row with a vehicle radar system
|
|
KR20200106912A
(ko)
|
2018-01-05 |
2020-09-15 |
에스디지,인코포레이티드 |
당뇨병을 치료하기 위한 지질 기반 나노입자를 포함하는 조성물
|